SIOPEL trials using preoperative chemotherapy in hepatoblastoma (Q34571873)

3 August 2017

1 reference

title

SIOPEL trials using preoperative chemotherapy in hepatoblastoma (English)

1 reference

3 August 2017

1 reference

G Perilongo

1

1 reference

3 August 2017

E Shafford

series ordinal

2

1 reference

3 August 2017

J Plaschkes

series ordinal

3

1 reference

3 August 2017

Liver Tumour Study Group of the International Society of Paediatric Oncology

series ordinal

4

1 reference

3 August 2017

publication date

1 October 2000

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

page(s)

94-100

1 reference

Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of pediatrics surgical section survey — 1974

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

1 reference

7 January 2021

Congenital hepatoblastoma: a distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Hepatoblastoma incidence in the United States from 1973 to 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Association between hepatoblastoma and very low birth weight: a trend or a chance?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Adriamycin and cisplatin for hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A siop pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Preoperative chemotherapy in 'unresectable' hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Liver Transplantation for Hepatoblastoma The American Experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Orthotopic liver transplantation for unresectable hepatoblastoma: a single center's experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Chemotherapy effects on hepatoblastoma. A histological study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900018-8

7 January 2021

10.1016/S1470-2045(00)00018-8

Identifiers

DOI

1 reference

3 August 2017

1 reference